WHO ICTRP trial
The human bioequivalence test of Epalrestai Tablets
ChiCTR2100041820 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100041820 |
|---|---|
| Public title | The human bioequivalence test of Epalrestai Tablets |
| Scientific title | Single-center, randomized, double-cycle, double-cross-design trial for evaluation of human bioequivalence for a single oral Epalrestai Tablets in Chinese healthy subjects under fasting conditions |
| Primary sponsor | Jiangsu Integrated Traditional Chinese and Western Medicine Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Diabetic neuropathy |
| Interventions | fasting congdition (pre-test):After fasting for at least 10 hours overnight, on the morning of the test day, one of the test preparations or one of the reference preparations was taken on an empty stomach with 240mL water. The drug was… |
| Registration date | Jan 6, 2021 |
| Target size | fasting congdition (pre-test):6;fasting congdition:28 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: